BioSpace News Archive

Late breaking oral presentation to highlight data from AMPLIFY, the Pivotal Phase 3 Study Evaluating Tenapanor in Dialysis Patients Who Have Uncontrolled Hyperphosphatemia Despite Phosphate Binder Treatment

Key research & development pipeline products and data to be presented, including 54-month Phase 2 vosoritide data update for the treatment of achondroplasia

DexCom, Inc. reported its financial results as of and for the quarter ended September 30, 2019.

Breakthrough Therapy Designation for Maralixibat for the Treatment of Pruritus Associated with Alagille Syndrome Granted

Aurinia Pharmaceuticals Inc. announced that it will release its third quarter 2019 financial results on Thursday, November 14, 2019, after the market closes.

Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company, today reported third quarter 2019 financial results and recent business highlights

Strong revenue growth and successful early launch of new HD-X Analyzer

Inspire Medical Systems, Inc., a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced that its management team will be presenting at the Stifel 2019 Healthcare Conference on November 19, 2019 at the Lotte New York Palace Hotel in New York.

Bellicum Pharmaceuticals, Inc., a leader in developing novel, controllable cellular immunotherapies for cancers, reported financial results for the third quarter 2019 and provided an operational update.

Geron Corporation reported financial results for the third quarter and year-to-date as of September 30, 2019 as well as recent events.